Avantor, Inc. Share Price

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
23.94 USD -4.81% Intraday chart for Avantor, Inc. -0.66% +4.86%
Sales 2024 * 6.94B 579B Sales 2025 * 7.33B 611B Capitalization 16.26B 1,357B
Net income 2024 * 440M 36.7B Net income 2025 * 622M 51.89B EV / Sales 2024 * 3.01 x
Net Debt 2024 * 4.66B 389B Net Debt 2025 * 3.9B 325B EV / Sales 2025 * 2.75 x
P/E ratio 2024 *
34.2 x
P/E ratio 2025 *
25.1 x
Employees 14,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 01/14/01
Director of Finance/CFO 54 07/23/07
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 54 01/21/01
Director/Board Member 68 07/20/07
Chairman 66 01/17/01
More insiders
Date Price Change Volume
26/24/26 23.94 -4.81% 14,185,165
25/24/25 25.15 -1.22% 6,252,933
24/24/24 25.46 -0.74% 6,282,431
23/24/23 25.65 +5.08% 5,609,607
22/24/22 24.41 +1.29% 5,532,766

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
23.94 USD
Average target price
27.75 USD
Spread / Average Target
+15.90%
Consensus